Go Pro
NASDAQ:BHST

BioHarvest Sciences Q2 2026 Earnings Report

BioHarvest Sciences logo
$2.18 +0.02 (+0.97%)
As of 01:07 PM Eastern
This is a fair market value price provided by Massive. Learn more.

BioHarvest Sciences EPS Results

Actual EPS
N/A
Consensus EPS
-$0.13
Beat/Miss
N/A
One Year Ago EPS
N/A

BioHarvest Sciences Revenue Results

Actual Revenue
N/A
Expected Revenue
$9.45 million
Beat/Miss
N/A
YoY Revenue Growth
N/A

BioHarvest Sciences Announcement Details

Quarter
Q2 2026
Time
Before Market Opens
Conference Call Date
Tuesday, August 11, 2026
Conference Call Time
8:00AM ET

Conference Call Resources

BioHarvest Sciences Earnings Headlines

Central banks bought 710 tonnes - this fund pays monthly
Gold is hitting new highs, fueled by tariffs and record central bank demand - 710 tonnes per quarter. JPMorgan is now targeting $4,900. One $15 fund is converting gold's momentum into up to $1,152 per month in payouts. No miners, no active trading - just monthly income.tc pixel
BioHarvest lands $1.4M grant for AI-driven plant science
BioHarvest lands $1.4M grant for AI-driven plant science
See More BioHarvest Sciences Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like BioHarvest Sciences? Sign up for Earnings360's daily newsletter to receive timely earnings updates on BioHarvest Sciences and other key companies, straight to your email.

About BioHarvest Sciences

BioHarvest Sciences (NASDAQ:BHST) is a biotechnology company that specializes in the development and commercialization of plant-based active ingredients through proprietary cell-culture technology. By growing undifferentiated plant cells in controlled bioreactor environments, the company aims to produce full-spectrum phytonutrients and botanical compounds that are difficult to obtain through traditional farming methods. This approach is designed to deliver consistent, high-purity extracts with reduced environmental impact and supply-chain variability.

The company’s product portfolio focuses on applications across the cosmeceutical, nutraceutical and health-and-wellness markets. Utilizing its “living plant cell” methodology, BioHarvest Sciences creates concentrates rich in natural antioxidants, peptides and other bioactive molecules. These ingredients are formulated for skin-care serums, dietary supplements and functional beverages, targeting consumers and manufacturers seeking clean-label and scientifically backed botanical solutions.

BioHarvest Sciences has pursued collaborative partnerships with research institutions and commercial enterprises to advance its cell-culture platform and expand market reach. While its technology development is headquartered in North America, the company’s ingredients have attracted interest from cosmetics and food firms in Europe and Asia. As it continues to scale production and refine its bioreactor processes, BioHarvest Sciences positions itself at the intersection of cellular agriculture and plant-derived therapeutics.

View BioHarvest Sciences Profile